Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study

S. Marini, M. Maggiorotti, N. Dardes, M. Bonetti, M. Martinelli, L. Re, F. Carinci, C. Tavera

Article ID: 4779
Vol 34, Issue 3, 2020
DOI: https://doi.org/10.23812/20-250-E-56
Received: 9 July 2020; Accepted: 9 July 2020; Available online: 9 July 2020; Issue release: 9 July 2020

Abstract

The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.


Keywords

COVID-19;SARS-COV-2;clinical study;oxygen-ozone;protocol


References

Supporting Agencies



Copyright (c) 2020 S. Marini, M. Maggiorotti, N. Dardes, M. Bonetti, M. Martinelli, L. Re, F. Carinci, C. Tavera




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).